These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29397420)

  • 1. Cluster: barriers of the central nervous system.
    Engelhardt B
    Acta Neuropathol; 2018 Mar; 135(3):307-310. PubMed ID: 29397420
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood-brain barrier--function of Mato cells].
    Muszyńska A; Zajkowska JM; Czupryna P; Moniuszko A; Pancewicz SA; Pawlak-Zalewska W
    Pol Merkur Lekarski; 2009 Jul; 27(157):55-7. PubMed ID: 19650432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound and Microbubble-Mediated Blood-Brain Barrier Disruption for Targeted Delivery of Therapeutics to the Brain.
    O'Reilly MA; Hynynen K
    Methods Mol Biol; 2018; 1831():111-119. PubMed ID: 30051428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel delivery methods bypassing the blood-brain and blood-tumor barriers.
    Hendricks BK; Cohen-Gadol AA; Miller JC
    Neurosurg Focus; 2015 Mar; 38(3):E10. PubMed ID: 25727219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis.
    Uchida Y; Sumiya T; Tachikawa M; Yamakawa T; Murata S; Yagi Y; Sato K; Stephan A; Ito K; Ohtsuki S; Couraud PO; Suzuki T; Terasaki T
    Mol Neurobiol; 2019 Mar; 56(3):2039-2056. PubMed ID: 29984400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging barriers: a comparative look at the blood-brain barrier across organisms.
    O'Brown NM; Pfau SJ; Gu C
    Genes Dev; 2018 Apr; 32(7-8):466-478. PubMed ID: 29692355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.
    Chapouly C; Tadesse Argaw A; Horng S; Castro K; Zhang J; Asp L; Loo H; Laitman BM; Mariani JN; Straus Farber R; Zaslavsky E; Nudelman G; Raine CS; John GR
    Brain; 2015 Jun; 138(Pt 6):1548-67. PubMed ID: 25805644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of disease: the blood-brain barrier.
    Neuwelt EA
    Neurosurgery; 2004 Jan; 54(1):131-40; discussion 141-2. PubMed ID: 14683550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of the blood-brain barrier.
    Wilhelm I; Nyúl-Tóth Á; Suciu M; Hermenean A; Krizbai IA
    Tissue Barriers; 2016; 4(1):e1143544. PubMed ID: 27141424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis.
    Danielski LG; Giustina AD; Badawy M; Barichello T; Quevedo J; Dal-Pizzol F; Petronilho F
    Mol Neurobiol; 2018 Feb; 55(2):1045-1053. PubMed ID: 28092082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia and Inflammation-Induced Disruptions of the Blood-Brain and Blood-Cerebrospinal Fluid Barriers Assessed Using a Novel T1-Based MRI Method.
    Nathoo N; Jalal H; Natah SS; Zhang Q; Wu Y; Dunn JF
    Acta Neurochir Suppl; 2016; 121():23-8. PubMed ID: 26463918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.
    Bosma EK; van Noorden CJF; Schlingemann RO; Klaassen I
    Fluids Barriers CNS; 2018 Sep; 15(1):24. PubMed ID: 30231925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance-associated proteins: expression and function in the central nervous system.
    Dallas S; Miller DS; Bendayan R
    Pharmacol Rev; 2006 Jun; 58(2):140-61. PubMed ID: 16714484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphogens and blood-brain barrier function in health and disease.
    Wevers NR; de Vries HE
    Tissue Barriers; 2016; 4(1):e1090524. PubMed ID: 27141417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles of the blood-brain barrier.
    András IE; Toborek M
    Tissue Barriers; 2016; 4(1):e1131804. PubMed ID: 27141419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadherin-10 is a novel blood-brain barrier adhesion molecule in human and mouse.
    Williams MJ; Lowrie MB; Bennett JP; Firth JA; Clark P
    Brain Res; 2005 Oct; 1058(1-2):62-72. PubMed ID: 16181616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diphenhydramine as a selective probe to study H
    Auvity S; Chapy H; Goutal S; Caillé F; Hosten B; Smirnova M; Declèves X; Tournier N; Cisternino S
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):2185-2195. PubMed ID: 27488910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-arachnoid barrier disruption in experimental rat meningitis detected using gadolinium-enhancement ratio imaging.
    Ichikawa H; Itoh K
    Brain Res; 2011 May; 1390():142-9. PubMed ID: 21435335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between metalloproteinases and cell signalling in blood brain barrier integrity.
    Pla-Navarro I; Bevan D; Hajihosseini MK; Lee M; Gavrilovic J
    Histol Histopathol; 2018 Dec; 33(12):1253-1270. PubMed ID: 29749591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier.
    Moura RP; Almeida A; Sarmento B
    Prog Neurobiol; 2017 Dec; 159():39-49. PubMed ID: 28899762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.